Alphabet Inc.
30 holdingsFiling period: 2026-06-30Current AUM: $165.97Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SPCX | Space Exploration Techn Corp | 551.19M | $94.18B | $80.97B | 48.79% | -- | 2026-06-30 |
| 2 | SPCX | Space Exploration Techn Corp | 551.19M | $94.18B | $80.97B | 48.79% | -- | 2026-06-30 |
| 3 | PL | Planet Labs Pbc | 35.25M | $1.17B | $485.0M | 0.29% | -- | 2026-06-30 |
| 4 | ASTS | Ast Spacemobile Inc | 8.94M | $794.7M | $352.8M | 0.21% | -- | 2026-06-30 |
| 5 | CME | Cme Group Inc | 3.48M | $769.4M | $1.07B | 0.65% | -- | 2026-06-30 |
| 6 | ARM | Arm Holdings PLC | 1.96M | $695.2M | $437.9M | 0.26% | -- | 2026-06-30 |
| 7 | RVMD | Revolution Medicines Inc | 2.95M | $551.8M | $541.9M | 0.33% | -345,906 | 2026-06-30 |
| 8 | FRSH | Freshworks Inc | 16.21M | $164.0M | $248.9M | 0.15% | -- | 2026-06-30 |
| 9 | PBLS | Parabilis Medicines Inc | 4.92M | $134.6M | $123.1M | 0.07% | -- | 2026-06-30 |
| 10 | TEM | Tempus AI Inc | 1.55M | $89.9M | $104.2M | 0.06% | -- | 2026-06-30 |
| 11 | GTLB | Gitlab Inc | 2.72M | $83.2M | $154.4M | 0.09% | -- | 2026-06-30 |
| 12 | PATH | Uipath Inc | 7.03M | $76.5M | $100.6M | 0.06% | -- | 2026-06-30 |
| 13 | LIFE | Ethos Technologies Inc | 3.62M | $65.7M | $153.2M | 0.09% | -147,552 | 2026-06-30 |
| 14 | PRME | Prime Medicine Inc | 16.56M | $61.1M | $59.8M | 0.04% | -- | 2026-06-30 |
| 15 | FRVO | Fervo Energy Co | 1.76M | $51.5M | $14.0M | 0.01% | -- | 2026-06-30 |
| 16 | PAYP | Paypay Corp | 3.13M | $44.8M | $44.8M | 0.03% | -- | 2026-06-30 |
| 17 | MAZE | Maze Therapeutics Inc | 1.39M | $41.4M | $43.1M | 0.03% | -- | 2026-06-30 |
| 18 | RLAY | Relay Therapeutics Inc | 1.41M | $26.4M | $25.5M | 0.02% | -154,144 | 2026-06-30 |
| 19 | BBOT | Bridgebio Oncology Therapeut | 2.82M | $21.5M | $7.5M | 0.00% | -- | 2026-06-30 |
| 20 | OSCR | Oscar Health Inc | 482.0K | $13.7M | $15.0M | 0.01% | -- | 2026-06-30 |
| 21 | BEAM | Beam Therapeutics Inc | 321.6K | $11.0M | $7.7M | 0.00% | -- | 2026-06-30 |
| 22 | VERA | Vera Therapeutics Inc | 241.3K | $10.4M | $6.8M | 0.00% | -- | 2026-06-30 |
| 23 | SANA | Sana Biotechnology Inc | 2.81M | $9.8M | $6.6M | 0.00% | -- | 2026-06-30 |
| 24 | GLUE | Monte Rosa Therapeutics Inc | 372.5K | $9.0M | $3.9M | 0.00% | -311,801 | 2026-06-30 |
| 25 | LYEL | Lyell Immunopharma Inc | 293.3K | $4.1M | $2.7M | 0.00% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2